Name | Number of supported studies | Average coverage | |
---|---|---|---|
mast cell | 15 studies | 29% ± 12% | |
natural killer cell | 9 studies | 23% ± 9% | |
regulatory T cell | 7 studies | 21% ± 4% | |
oligodendrocyte | 6 studies | 24% ± 9% | |
gamma-delta T cell | 4 studies | 25% ± 2% | |
squamous epithelial cell | 3 studies | 36% ± 18% | |
CD16-negative, CD56-bright natural killer cell, human | 3 studies | 27% ± 7% | |
innate lymphoid cell | 3 studies | 22% ± 7% | |
granulocyte | 3 studies | 26% ± 8% | |
oligodendrocyte precursor cell | 3 studies | 27% ± 9% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 18% ± 1% |
Insufficient scRNA-seq data for expression of DUSP10 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 1760.08 | 226 / 226 | 99% | 34.88 | 402 / 406 |
breast | 100% | 830.98 | 458 / 459 | 98% | 33.97 | 1094 / 1118 |
lung | 99% | 661.19 | 575 / 578 | 97% | 25.81 | 1123 / 1155 |
intestine | 98% | 887.40 | 947 / 966 | 96% | 17.67 | 508 / 527 |
pancreas | 96% | 669.95 | 316 / 328 | 98% | 26.52 | 174 / 178 |
skin | 100% | 1728.54 | 1807 / 1809 | 93% | 40.60 | 439 / 472 |
esophagus | 97% | 470.88 | 1408 / 1445 | 93% | 19.09 | 171 / 183 |
bladder | 95% | 377.67 | 20 / 21 | 89% | 24.68 | 451 / 504 |
thymus | 97% | 361.49 | 635 / 653 | 85% | 11.97 | 516 / 605 |
uterus | 84% | 305.14 | 142 / 170 | 95% | 27.96 | 437 / 459 |
prostate | 96% | 371.65 | 235 / 245 | 80% | 9.34 | 401 / 502 |
stomach | 79% | 283.60 | 284 / 359 | 94% | 16.78 | 270 / 286 |
adrenal gland | 93% | 381.50 | 241 / 258 | 78% | 11.72 | 180 / 230 |
brain | 92% | 376.84 | 2429 / 2642 | 79% | 12.17 | 556 / 705 |
kidney | 61% | 178.76 | 54 / 89 | 78% | 10.34 | 701 / 901 |
ovary | 48% | 137.49 | 86 / 180 | 81% | 15.22 | 350 / 430 |
lymph node | 0% | 0 | 0 / 0 | 100% | 32.28 | 29 / 29 |
spleen | 100% | 458.14 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 24.22 | 1 / 1 |
adipose | 99% | 519.56 | 1190 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 23.86 | 44 / 45 |
muscle | 95% | 760.95 | 761 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 84% | 270.41 | 1124 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 82% | 1233.02 | 760 / 929 | 0% | 0 | 0 / 0 |
heart | 76% | 205.07 | 652 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 11% | 1.34 | 9 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048715 | Biological process | negative regulation of oligodendrocyte differentiation |
GO_0060266 | Biological process | negative regulation of respiratory burst involved in inflammatory response |
GO_0090335 | Biological process | regulation of brown fat cell differentiation |
GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
GO_0035970 | Biological process | peptidyl-threonine dephosphorylation |
GO_0035335 | Biological process | peptidyl-tyrosine dephosphorylation |
GO_0050680 | Biological process | negative regulation of epithelial cell proliferation |
GO_0002819 | Biological process | regulation of adaptive immune response |
GO_0043508 | Biological process | negative regulation of JUN kinase activity |
GO_0051403 | Biological process | stress-activated MAPK cascade |
GO_0032873 | Biological process | negative regulation of stress-activated MAPK cascade |
GO_1905042 | Biological process | negative regulation of epithelium regeneration |
GO_0046329 | Biological process | negative regulation of JNK cascade |
GO_0016311 | Biological process | dephosphorylation |
GO_0048709 | Biological process | oligodendrocyte differentiation |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0010633 | Biological process | negative regulation of epithelial cell migration |
GO_1990264 | Biological process | peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity |
GO_0045591 | Biological process | positive regulation of regulatory T cell differentiation |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_1903753 | Biological process | negative regulation of p38MAPK cascade |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0008432 | Molecular function | JUN kinase binding |
GO_0017018 | Molecular function | myosin phosphatase activity |
GO_0048273 | Molecular function | mitogen-activated protein kinase p38 binding |
GO_0017017 | Molecular function | MAP kinase tyrosine/serine/threonine phosphatase activity |
GO_0033549 | Molecular function | MAP kinase phosphatase activity |
GO_0008330 | Molecular function | protein tyrosine/threonine phosphatase activity |
GO_0016791 | Molecular function | phosphatase activity |
GO_0033550 | Molecular function | MAP kinase tyrosine phosphatase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | DUSP10 |
Protein name | Dual specificity protein phosphatase 10 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 5) (MAP kinase phosphatase 5) (MKP-5) Dual specificity phosphatase 10 protein-serine/threonine phosphatase (EC 3.1.3.16) |
Synonyms | MKP5 |
Description | FUNCTION: Protein phosphatase involved in the inactivation of MAP kinases. Has a specificity for the MAPK11/MAPK12/MAPK13/MAPK14 subfamily. It preferably dephosphorylates p38. . |
Accessions | Q6IAR2 Q9Y6W6 ENST00000477026.5 ENST00000468085.5 A0A0B4J2F5 ENST00000366899.4 [Q9Y6W6-1] ENST00000494642.1 |